PMV Pharmaceuticals, Inc. (PMVP) Tops Q3 EPS by 12c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. CVS
8. SWKS
9. SPY
10. XYZ

Go back to PMV Pharmaceuticals, Inc. (PMVP) Tops Q3 EPS by 12c

PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights

November 9, 2023 8:01 AM EST

Updated data from Phase 1 PYNNACLE clinical trial of PC14586 presented at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics demonstrated responses across multiple tumor types with median duration of response of seven monthsAn overall response rate of 38% observed at the recommended Phase 2 dose of 2000 mg daily for the intended Phase 2 population of TP53 Y220C and KRAS wild-type patientsRegistrational Phase 2 clinical trial expected to initiate in Q1... More